← FDA Drug Approvals (Drugs@FDA)

EFAVIRENZ

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CIPLA LIMITED · Approved 2009-08-03

Drug application

FDA Application #

ANDA090155

Application type

Abbreviated New Drug Application (Generic)

Brand name

EFAVIRENZ

Generic name

Efavirenz

Active ingredients

EFAVIRENZ

Dosage form

CAPSULE

Route

ORAL

Marketing status

None (Tentative Approval)

Sponsor

CIPLA LIMITED

First approval

2009-08-03

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown